Key result
Cortical bone stem cell therapy promotes reparative macrophage polarization and reduces apoptosis after swine MI.
Cortical bone stem cell therapy may alter the inflammatory response to cardiac injury by inducing a unique macrophage phenotype and modulating macrophage/fibroblast cross talk.
Should not alter post-MI care; hypothesis-generating for stem cell effects on macrophage-fibroblast signaling.
Acute damage to the heart, as in the case of myocardial infarction (MI), triggers a robust inflammatory response to the sterile injury that is part of a complex and highly organized wound-healing process. Cortical bone stem cell (CBSC) therapy after MI has been shown to reduce adverse structural and functional remodeling of the heart after MI in both mouse and swine models. The basis for these CBSC treatment effects on wound healing are unknown. The present experiments show that CBSCs secrete paracrine factors known to have immunomodulatory properties, most notably macrophage colony-stimulating factor (M-CSF) and transforming growth factor-β, but not IL-4. CBSC therapy increased the number of galectin-3+ macrophages, CD4+ T cells, and fibroblasts in the heart while decreasing apoptosis in an in vivo swine model of MI. Macrophages treated with CBSC medium in vitro polarized to a proreparative phenotype are characterized by increased CD206 expression, increased efferocytic ability, increased IL-10, TGF-β, and IL-1RA secretion, and increased mitochondrial respiration. Next generation sequencing revealed a transcriptome significantly different from M2a or M2c macrophage phenotypes. Paracrine factors from CBSC-treated macrophages increased proliferation, decreased α-smooth muscle actin expression, and decreased contraction by fibroblasts in vitro. These data support the idea that CBSCs are modulating the immune response to MI to favor cardiac repair through a unique macrophage polarization that ultimately reduces cell death and alters fibroblast populations that may result in smaller scar size and preserved cardiac geometry and function.NEW & NOTEWORTHY Cortical bone stem cell (CBSC) therapy after myocardial infarction alters the inflammatory response to cardiac injury. We found that cortical bone stem cell therapy induces a unique macrophage phenotype in vitro and can modulate macrophage/fibroblast cross talk.
No takes yet. Share an insight, caveat, or question.
Hobby et al. (2021) studied Myocardial infarction. Cortical bone stem cell (CBSC) therapy was evaluated on Cardiac immune response, macrophage polarization, and fibroblast activity. Cortical bone stem cell therapy increased galectin-3+ macrophages, CD4+ T cells, and fibroblasts while decreasing apoptosis in a swine MI model, polarizing macrophages to a unique reparative state.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: